NEW YORK, Jan. 9 - Bruker AXS on Wednesday said that the underwriters of its initial public offering have exercised their over-allotment option and purchased an additional 1.35 million shares of common stock at $6.50 per share.
...and receive Daily News bulletins.
Already have an account?Login Now.
In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.
At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.
The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.
Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.